786 related articles for article (PubMed ID: 27487431)
1. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
2. Positively Charged Surface-Modified Solid Lipid Nanoparticles Promote the Intestinal Transport of Docetaxel through Multifunctional Mechanisms in Rats.
Shi LL; Xie H; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Mol Pharm; 2016 Aug; 13(8):2667-76. PubMed ID: 27379550
[TBL] [Abstract][Full Text] [Related]
3. Rhodojaponin III-Loaded Chitosan Derivatives-Modified Solid Lipid Nanoparticles for Multimodal Antinociceptive Effects in vivo.
Yang Q; Yang J; Sun S; Zhao J; Liang S; Feng Y; Liu M; Zhang J
Int J Nanomedicine; 2022; 17():3633-3653. PubMed ID: 35996527
[TBL] [Abstract][Full Text] [Related]
4. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
5. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
6. Preparation of Deoxycholate-Modified Docetaxel-Cimetidine Complex Chitosan Nanoparticles to Improve Oral Bioavailability.
Xu Y; Fang T; Yang Y; Sun L; Shen Q
AAPS PharmSciTech; 2019 Sep; 20(7):302. PubMed ID: 31489504
[TBL] [Abstract][Full Text] [Related]
7. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method.
Nabi-Meibodi M; Vatanara A; Najafabadi AR; Rouini MR; Ramezani V; Gilani K; Etemadzadeh SM; Azadmanesh K
Colloids Surf B Biointerfaces; 2013 Dec; 112():408-14. PubMed ID: 24036624
[TBL] [Abstract][Full Text] [Related]
8. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
10. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
Chen CC; Tsai TH; Huang ZR; Fang JY
Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
[TBL] [Abstract][Full Text] [Related]
11. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
13. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
[TBL] [Abstract][Full Text] [Related]
14. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.
Zhang Y; Zhu W; Zhang H; Han J; Zhang L; Lin Q; Ai F
Int J Pharm; 2017 Oct; 532(1):384-392. PubMed ID: 28903067
[TBL] [Abstract][Full Text] [Related]
15. Enhanced oral delivery of docetaxel using thiolated chitosan nanoparticles: preparation, in vitro and in vivo studies.
Saremi S; Dinarvand R; Kebriaeezadeh A; Ostad SN; Atyabi F
Biomed Res Int; 2013; 2013():150478. PubMed ID: 23971023
[TBL] [Abstract][Full Text] [Related]
16. Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide.
Gonçalves LM; Maestrelli F; Di Cesare Mannelli L; Ghelardini C; Almeida AJ; Mura P
Eur J Pharm Biopharm; 2016 May; 102():41-50. PubMed ID: 26925503
[TBL] [Abstract][Full Text] [Related]
17. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
18. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake.
Xu Q; Zhu T; Yi C; Shen Q
Drug Dev Ind Pharm; 2016 May; 42(5):701-706. PubMed ID: 26258801
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
20. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
Han HK; Shin HJ; Ha DH
Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]